← Leaderboards
Colin P Dinney
University Of Texas Md Anderson Can Ctr
$4,248,660
Attributed
$7,332,942
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$44,702,462 · 12
By mechanism
P50$41,066,963 · 9
R01$3,115,408 · 1
P01$412,360 · 1
R29$107,731 · 1
Top collaborators
- David J Mcconkey13 shared
- William Francis Benedict6 shared
- Raghu Kalluri5 shared
- Arlene O Siefker-Radtke5 shared
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- David J McConkey$4,498,182
- Veronique M Lefebvre$17,895,341
- William Francis Benedict$3,785,293
- Menashe Bareli$6,643,202
- John L Clifford$553,681
Others in their field
Top investigators on “Malignant Neoplasm Of Urinary Bladder”
- David Heimbrook · Leidos Biomedical Research, Inc.$89,819,252
- Walter John Curran · Thomas Jefferson University$36,890,150
- Norman Wolmark · Nsabp Foundation, Inc.$33,598,810
- Robert S Mannel · University Of Oklahoma Hlth Sciences Ctr$33,598,810
- Quynh-Thu X Le · Stanford University$23,198,964
- Larry Arthur$21,899,494
Research focus
Malignant Neoplasm Of Urinary BladderBaseUrogenital CancerTranslational ResearchProgramsResearch PersonnelTumorCellsUniversity Of Texas M D Anderson Cancer CenterBiological MarkersBioinformaticsMutationClinical TrialsFundingBiometryData ManagementResponseEventReportingBiologicalGenesPlayQuality ControlInnovation
Grant awards (44)
Project 3: Identifying Molecular Vulnerabilities to Improve Interferon Gene Therapy in Bladder Cancer$412,360
P01 · FY2025 · CA · contact PI
Rigorous and reproducible mutational analysis of the urinary exosomal DNA$604,956
R01 · FY2023 · CA
Rigorous and reproducible mutational analysis of the urinary exosomal DNA$604,526
R01 · FY2022 · CA
Rigorous and reproducible mutational analysis of the urinary exosomal DNA$616,430
R01 · FY2021 · CA
Rigorous and reproducible mutational analysis of the urinary exosomal DNA$672,829
R01 · FY2020 · CA
Rigorous and reproducible mutational analysis of the urinary exosomal DNA$616,667
R01 · FY2019 · CA
SPORE in Genitourinary Cancer$1,162,609
P50 · FY2018 · CA · contact PI
SPORE in Genitourinary Cancer$1,910,080
P50 · FY2016 · CA · contact PI
Administrative Core$218,137
P50 · FY2016 · CA · contact PI
Targeting FGFR and EGFR in Bladder Cancer$215,813
P50 · FY2016 · CA
SPORE in Genitourinary Cancer$1,930,400
P50 · FY2015 · CA · contact PI
Administrative Core$219,381
P50 · FY2015 · CA · contact PI
Targeting FGFR and EGFR in Bladder Cancer$217,028
P50 · FY2015 · CA
SPORE in Genitourinary Cancer$1,910,079
P50 · FY2014 · CA · contact PI
Administrative Core$216,885
P50 · FY2014 · CA · contact PI
Targeting FGFR and EGFR in Bladder Cancer$214,680
P50 · FY2014 · CA
SPORE in Genitourinary Cancer$1,899,920
P50 · FY2013 · CA · contact PI
Administrative Core$215,641
P50 · FY2013 · CA · contact PI
Targeting FGFR and EGFR in Bladder Cancer$213,501
P50 · FY2013 · CA
SPORE in Genitourinary Cancer$2,032,000
P50 · FY2012 · CA · contact PI
Targeting FGFR and EGFR in Bladder Cancer$203,201
P50 · FY2012 · CA
Intravesical Gene Therapy for BCG Refractory Bladder Cancer$203,200
P50 · FY2012 · CA
Administrative Core$203,200
P50 · FY2012 · CA · contact PI
SPORE in Genitourinary Cancer$2,233,298
P50 · FY2010 · CA · contact PI
Administrative Core$192,292
P50 · FY2010 · CA · contact PI
Career Developement Program$147,190
P50 · FY2010 · CA · contact PI
Developmental Research Program$147,190
P50 · FY2010 · CA · contact PI
SPORE in Genitourinary Cancer$2,233,299
P50 · FY2009 · CA · contact PI
Administrative Core$194,222
P50 · FY2009 · CA · contact PI
Career Developement Program$148,668
P50 · FY2009 · CA · contact PI
Developmental Research Program$148,668
P50 · FY2009 · CA · contact PI
SPORE in Genitourinary Cancer$117,418
P50 · FY2009 · CA · contact PI
SPORE in Genitourinary Cancer$2,489,653
P50 · FY2008 · CA · contact PI
Administrative Core$149,570
P50 · FY2008 · CA · contact PI
Developmental Research Program$114,488
P50 · FY2008 · CA · contact PI
Career Developement Program$114,488
P50 · FY2008 · CA · contact PI
SPORE in Genitourinary Cancer$2,549,962
P50 · FY2007 · CA · contact PI
SPORE in Genitourinary Cancer$2,554,804
P50 · FY2006 · CA · contact PI
M. D. Anderson Cancer SPORE in Genitourinary Cancers$2,870,563
P50 · FY2005 · CA
M. D. Anderson Cancer SPORE in Genitourinary Cancers$2,870,563
P50 · FY2004 · CA
M. D. Anderson Cancer SPORE in Genitourinary Cancers$3,132,347
P50 · FY2003 · CA
M. D. Anderson Cancer SPORE in Genitourinary Cancers$2,971,514
P50 · FY2002 · CA
M. D. Anderson Cancer SPORE in Genitourinary Cancers$2,501,011
P50 · FY2001 · CA
BIOLOGY OF BLADDER CANCER METASTASES$107,731
R29 · FY2000 · CA